Botanical Safety Consortium HFP Priority 135.1
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- Points of contact
-
- tbd@fda.gov
- Laquia Geathers laquia.geathers@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking to establish the Botanical Safety Consortium (BSC), a collaborative research initiative focused on improving the safety assessment of botanical dietary supplements. The project aims to review scientific literature, identify safety signals, and develop enhanced regulatory frameworks for evaluating dietary supplement ingredients. The estimated solicitation release date is July 1, 2026, with an expected contract award date of September 1, 2026.
The total contract value is $266,850, comprised of $166,850 from ODSP funding and $100,000 from NIH funding, classified under NAICS code 541720 for Research and Development in Social Sciences and Humanities. The consortium will involve multiple stakeholders including the National Institute of Environmental Health Sciences (NIEHS), FDA, and the Health and Environmental Sciences Institute (HESI). Key points of contact include Laquia Geathers (laquia.geathers@fda.hhs.gov) from the Food and Drug Administration, with additional communication potentially available through the provided email tbd@fda.gov.
Forecast text
HFP Priority 135.1 Botanical Safety Consortium - Assisted acq. IAA with Department of Interior (no G-Invoicing). Total cost is $266,850 ($166,850 ODSP Funded and $100K NIH Funded). Ensuring the safety of botanical dietary supplements is an important public health priority due to widespread use, reports of adverse events associated with exposure, the impressive number of diverse botanicals in the market, and noted variability in the quality and consistency of those products. The Botanical Safety Consortium (BSC) involving the National Institute of Environmental Health Sciences (NIEHS), the Food and Drug Administration (FDA), and the Health and Environmental Sciences Institute (HESI), provides the framework for collaborative efforts across these three and and other stakeholders to support the development of science that will improve the quality and safety assessment of botanical dietary supplements via the consortium. Review the scientific literature relative to dietary supplements/ingredients to identify signals related to safety concerns and how to address these concerns in the current regulatory framework.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast